GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 52 filers reported holding GALERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $680 | +30.5% | 217,900 | +7.1% | 0.00% | 0.0% |
Q1 2023 | $521 | +727.0% | 203,500 | +378.8% | 0.00% | – |
Q4 2022 | $63 | -100.0% | 42,500 | -73.1% | 0.00% | – |
Q3 2022 | $275,000 | -12.7% | 157,768 | -34.9% | 0.00% | – |
Q2 2022 | $315,000 | -69.9% | 242,352 | -44.8% | 0.00% | -100.0% |
Q1 2022 | $1,045,000 | +444.3% | 439,134 | +1755.2% | 0.00% | – |
Q3 2021 | $192,000 | -19.3% | 23,670 | -2.1% | 0.00% | – |
Q2 2021 | $238,000 | -27.2% | 24,170 | -34.8% | 0.00% | – |
Q1 2021 | $327,000 | +54.2% | 37,081 | +78.5% | 0.00% | – |
Q4 2020 | $212,000 | +79.7% | 20,770 | +58.9% | 0.00% | – |
Q3 2020 | $118,000 | -25.3% | 13,070 | -40.8% | 0.00% | – |
Q2 2020 | $158,000 | – | 22,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |